Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | Thalidomide-O-amido-C8-NH2 (Cereblon Ligand-Linker Conjugates 2) is a synthesized E3 ligase ligand-linker conjugate containing a Thalidomide-based cereblon ligand and a linker, useful in the synthesis of PROTACs, as per reference [1]. |
In vitro | Thalidomide-O-amido-C8-NH2, referred to as Compound DL7-TL, serves as a degron-linker within the PROTAC framework, covalently connecting to both a degron and a targeting ligand. This configuration enables the degron, a molecule that binds to ubiquitin ligases (e.g., cereblon), to guide the targeting ligand toward specific proteins[1], facilitating their ubiquitination and subsequent degradation. |
Alias | E3 Ligase Ligand-Linker Conjugates 20, Cereblon Ligand-Linker Conjugates 2 |
Molecular Weight | 458.51 |
Formula | C23H30N4O6 |
Cas No. | 1950635-15-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.